Search

Your search keyword '"Fargion A"' showing total 388 results

Search Constraints

Start Over You searched for: Author "Fargion A" Remove constraint Author: "Fargion A" Topic medicine.disease Remove constraint Topic: medicine.disease
388 results on '"Fargion A"'

Search Results

1. Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry

2. Preoperative and postoperative predictors of clinical outcome of fenestrated and branched endovascular repair for complex abdominal and thoracoabdominal aortic aneurysms in an Italian multicenter registry

3. Role of historical and procedural staging during elective fenestrated and branched endovascular treatment of extensive thoraco-abdominal aortic aneurysms

4. Dysmetabolic Hyperferritinemia and Dysmetabolic Iron Overload Syndrome (DIOS): Two Related Conditions or Different Entities?

5. Liver involvement in Gaucher disease: A practical review for the hepatologist and the gastroenterologist

6. FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage

7. Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry

8. Stability of the aneurysmatic sac post-EVAR could no longer be a reliable criterion of healing

9. Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC

10. Brain involvement in non-alcoholic fatty liver disease (NAFLD): A systematic review

11. Evaluation of three 'beyond Baveno VI' criteria to safely spare endoscopies in compensated advanced chronic liver disease

12. Hybrid Surgical Approach to a Giant Post-Coarctation Aortic Aneurysm

13. Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids

14. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

15. Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease

16. MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals

17. Fibronectin Type III Domain–Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

18. NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes

19. Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLD

20. Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes

21. Cardiovascular involvement after liver transplantation: role of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

22. Bilateral Use of Iliac Branch Devices for Aortoiliac Aneurysms Is Safe and Feasible, and Procedural Volume Does Not Seem to Affect Technical or Clinical Effectiveness: Early and Midterm Results From the pELVIS International Multicentric Registry

23. Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD}

24. Increased rates of hand ischemia following arterial cannulation in patients with severe COVID19-related pneumonia

25. Extravascular risk factors in the prognostic evaluation for spinal cord injury during thoraco-abdominal aortic aneurysm exclusion: a case report

26. Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP)

27. Progressive splenomegaly and mild thrombocytosis in beta-thalassaemia trait and coexisting hereditary hemochromatosis: possible confounders for a subsequent hematological diagnosis

28. Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients

29. Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation

30. Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis

31. Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study

32. Outcomes From the Multicenter Italian Registry on Primary Endovascular Treatment of Aortoiliac Occlusive Disease

33. Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis

34. Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease

35. PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients

36. Acquired hepatocerebral degeneration (AHD): a peculiar neurological impairment in advanced chronic liver disease

37. PCSK9 deficiency results in increased ectopic fat accumulation in experimental models and in humans

38. Secondary Procedures Following Iliac Branch Device Treatment of Aneurysms Involving the Iliac Bifurcation: The pELVIS Registry

39. Iliac Branch Devices With Standard vs Fenestrated/Branched Stent-Grafts: Does Aneurysm Complexity Produce Worse Outcomes? Insights From the pELVIS Registry

40. A pilot study of the enhanced recovery after surgery protocol in aortic surgery

41. MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease

42. Combined use of Genetic Polymorphisms and Elastographic Techniques in NAFLD: Fact or Fiction?

43. P179Absence of cardiac siderosis at cardiac magnetic resonance in patients with dysmetabolic hyperferritinemia

44. Procoagulant imbalance influences cardiovascular and liver damage in chronic hepatitis C independently of steatosis

45. Use and prescription appropriateness of drugs for peptic ulcer and gastrooesophageal reflux disease in hospitalized older people

46. Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study

47. Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients

48. Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients

49. Pattern of in-hospital changes in drug use in the older people from 2010 to 2016

50. Hepatitis C virus eradication by direct antiviral agents improves carotid atherosclerosis in patients with advanced fibrosis/compensated cirrhosis

Catalog

Books, media, physical & digital resources